CorMedix (CRMD)
(Delayed Data from NSDQ)
$5.19 USD
-0.14 (-2.63%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $5.19 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
CorMedix Inc [CRMD]
Reports for Purchase
Showing records 61 - 80 ( 101 total )
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Phase 3 Program Progress; 1Q 2016 Results Reported; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
1Q16 Recap - Interim Analysis on Track for 4Q16
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
FY2015 Results Reported; Neutrolin® Program Advancing; Reiterate Buy and Raising Price Target
Provider: Rodman & Renshaw, Co.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
FY2015 Results Reported; Neutrolin® Program Advancing; Reiterate Buy and Raising Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Discouraging Trading Trends Beg the Question: What Will Happen to the Russell 3000?
Provider: Rodman & Renshaw, Co.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Phase 3 Trial Initiated on Schedule; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Phase 3 Trial Initiated on Schedule; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
3Q15 Recap - Choppy Ex-US Sales, U.S. Timeline on Track
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
3Q15 Results Reported: Phase 3 Program Starting; Reiterate Buy
Provider: Rodman & Renshaw, Co.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
3Q15 Results Reported: Phase 3 Program Starting; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Initiating Coverage with Buy and $6.50 Price Target
Provider: H.C. Wainwright & Co., Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Initiating Coverage with Buy and $6.50 Price Target
Provider: Rodman & Renshaw, Co.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
Strategic Update - Trial to Start Soon, but No Company Sale
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: CorMedix Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.